Relapsing Multiple Sclerosis (RMS) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 127 pages | ID: R21C30F3389EN
VPAResearch

Abstracts

Relapsing Multiple Sclerosis (RMS) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Relapsing Multiple Sclerosis (RMS) disease clinical trials. The research work analyzes the ongoing Relapsing Multiple Sclerosis (RMS) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Relapsing Multiple Sclerosis (RMS) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Relapsing Multiple Sclerosis (RMS) clinical trials.

Scope of the Report-

• Ongoing Relapsing Multiple Sclerosis (RMS) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Relapsing Multiple Sclerosis (RMS)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Relapsing Multiple Sclerosis (RMS) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Relapsing Multiple Sclerosis (RMS) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Relapsing Multiple Sclerosis (RMS) Trials by Phase
3.2 Ongoing Relapsing Multiple Sclerosis (RMS) Trials by Type
3.3 Ongoing Relapsing Multiple Sclerosis (RMS) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Relapsing Multiple Sclerosis (RMS) Trials
4.2 Top 10 Countries conducting Relapsing Multiple Sclerosis (RMS) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Relapsing Multiple Sclerosis (RMS) Trials by Sponsor Type
5.2 Relapsing Multiple Sclerosis (RMS) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Relapsing Multiple Sclerosis (RMS) Trials by year
6.2 Subjects Recruited for Relapsing Multiple Sclerosis (RMS) Trials by Phase
6.3 Subjects Recruited for Relapsing Multiple Sclerosis (RMS) Trials by Trial Type
6.4 Subjects Recruited for Relapsing Multiple Sclerosis (RMS) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Relapsing Multiple Sclerosis (RMS) Trials- Phase
7.2 Ongoing Relapsing Multiple Sclerosis (RMS) Trials- Phase
7.3 Ongoing Relapsing Multiple Sclerosis (RMS) Trials- Phase
7.4 Ongoing Relapsing Multiple Sclerosis (RMS) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Country
Figure 2: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Phase of Development, 2018
Figure 3: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Status, 2018
Figure 4: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Type, 2018
Figure 5: Relapsing Multiple Sclerosis (RMS)- Clinical Trials Split by Region, 2000-2018
Figure 6: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Type of Economy, 2018
Figure 7: Relapsing Multiple Sclerosis (RMS)- Enrolment by Phase, 2018
Figure 8: Relapsing Multiple Sclerosis (RMS)- Enrolment by Trial Type, 2018
Figure 9: Relapsing Multiple Sclerosis (RMS)- Enrolment by Recruitment Status, 2018
Figure 10: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Sponsor Type, 2018
Figure 11: Relapsing Multiple Sclerosis (RMS)- Enrolment by Type of Sponsors
Figure 12: Relapsing Multiple Sclerosis (RMS)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Sponsor Type, 2018
Table 2: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Economy Type, 2018
Table 3: Relapsing Multiple Sclerosis (RMS)- Clinical Trials by Region, 2018
Table 4: Relapsing Multiple Sclerosis (RMS)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Relapsing Multiple Sclerosis (RMS)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Relapsing Multiple Sclerosis (RMS)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Relapsing Multiple Sclerosis (RMS)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Relapsing Multiple Sclerosis (RMS)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Relapsing Multiple Sclerosis (RMS)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company